Arrowgrass Capital Partners (Us) Lp (CIK: 0001454288) is a financial institution headquartered at 245 Park Avenue, 39Th Floor, , New York, New York 10167. The firm regularly files Form 13F with the U.S. Securities and Exchange Commission (SEC), disclosing its equity holdings and investment positions.
As of the latest reporting period (2019-12-31), the institution manages a portfolio valued at $380.08 M, comprising 65 distinct securities. Over its filing history, it has submitted 27 Form 13F reports.
To view the institution’s full SEC filing history:
🔗 View All SEC Filings
Q4 2019 — Top-10 concentration: 89.1%. Quarterly turnover: 0.1%. ▲ 1 new, +7 added, −14 reduced, ×51 exited.
| Name | Shares | Market Value | Weight | Change | Activity |
|---|---|---|---|---|---|
| 329,499 | $8.06 M | 2.12% | ▲ 3,829 | Add 1.2% | |
| 65,970 | $5.84 M | 1.54% | ▼ 88,100 | Reduce -57.2% | |
| 141,992 | $5.56 M | 1.46% | ▲ 6,238 | Add 4.6% | |
| 144,254 | $4.14 M | 1.09% | ▼ 82,039 | Reduce -36.3% | |
| 30,000 | $3.79 M | 1.00% | ▼ 11,623 | Reduce -27.9% | |
| 110,660 | $3.33 M | 0.88% | |||
| 59,873 | $2.19 M | 0.58% | ▲ 7,927 | Add 15.3% | |
|
Alexion Pharmaceuticals
N/A
|
17,461 | $1.89 M | 0.50% | ▼ 4,492 | Reduce -20.5% |
| 40,200 | $1.62 M | 0.43% | ▼ 86,117 | Reduce -68.2% | |
| 5,389 | $708,000 | 0.19% | ▼ 17,323 | Reduce -76.3% |